Introduction {#cesec10}
============

The international community is mobilising to limit the spread of severe acute respiratory syndrome coronavirus 2 and reduce mortality from COVID-19. As of May 1, 2020, more than 237 000 people have died from COVID-19, and estimates of future deaths number in the millions.[@bib1], [@bib2] Governments are responding at local, national, regional, and global levels, and health officials are developing guidance for health systems and the public.[@bib3] In weighing their options, policy makers must consider not only the immediate health effects of the pandemic but also the indirect effects of the pandemic and the response to it. An analysis of the 2014 outbreak of Ebola virus in west Africa showed that the indirect effects of the outbreak were more severe than the outbreak itself.[@bib4] Although mortality rates for COVID-19 appear to be low in children and in women of reproductive age,[@bib5] these groups might be disproportionately affected by the disruption of routine health services, particularly in low-income and middle-income countries (LMICs). With this in mind, we sought to quantify the potential indirect effects of the COVID-19 pandemic on maternal and child mortality.

In past epidemics, health systems have struggled to maintain routine services and utilisation of services has decreased.[@bib6] As WHO notes, "People, efforts, and medical supplies all shift to respond to the emergency. This often leads to the neglect of basic and regular essential health services. People with health problems unrelated to the epidemic find it harder to get access to health care services."[@bib7] A study of the 2014 epidemic of Ebola virus disease estimated that, during the outbreak, antenatal care coverage decreased by 22 percentage points, and there were declines in the coverage of family planning (6 percentage points), facility delivery (8 percentage points), and postnatal care (13 percentage points).[@bib8] Qualitative studies suggest that these reductions were due to fear of contracting Ebola virus at health facilities, distrust of the health system, and rumours about the source of the disease.[@bib9] During the 2003 severe acute respiratory syndrome epidemic, ambulatory care decreased by 23·9% in Taiwan and inpatient care decreased by 35·2%.[@bib10] Simulated models of influenza pandemics also predict reductions in utilisation of health services.[@bib11]

Research in context**Evidence before this study**The global community is responding in unprecedented ways to limit the spread of severe acute respiratory syndrome coronavirus 2 and reduce mortality from COVID-19. Global organisations have called for maintaining routine health services during the pandemic; however, the potential indirect effects on mortality from maternal and child health service disruption have not been quantified. Previous infectious disease outbreaks indirectly resulted in increases in mortality caused by reductions in the provision and use of routine health services. Notably, the 2014 Ebola virus epidemic resulted in a 27·6 percentage point decrease in service use and 44·3 percentage point decrease in inpatient services in high-incidence areas of west Africa. During the 2003 epidemic of severe acute respiratory syndrome, a 23·9% reduction in ambulatory care and a 35·2% reduction in inpatient care was observed in Taiwan. Similar indirect effects are plausible as a result of the COVID-19 pandemic and control efforts.**Added value of this study**We quantified the potential indirect effect of the COVID-19 pandemic and control efforts on reproductive, maternal, newborn, and child health in 118 low-income and middle-income countries (LMICs) using the Lives Saved Tool. We modelled the effects on maternal and under-5 mortality of three outbreak scenarios and attributed the excess mortality to reductions in specific interventions or increases in risk factors. Our analysis shows that, if the COVID-19 pandemic results in widespread disruption to health systems, LMICs can expect to see substantial increases in maternal and child deaths. Childbirth care and child curative services are particularly vulnerable to disruption and would account for the greatest number of additional maternal and child deaths.**Implications of all the available evidence**Our analysis does not aim to predict the trajectory of the pandemic response in LMICs. Quantification of the indirect effects of the pandemic is intended to serve as a benchmark for policy makers. The choices that governments make in responding to the pandemic will have consequences for the health and livelihoods of populations. In the context of these choices, our estimates highlight the need to consider how to mitigate the effect of health system disruptions and movement restrictions on maternal and child health. Our analysis provides a framework that policy makers can use to prioritise interventions and quantify the secondary effects of resource allocation and control measures, to inform decisions around health system continuity and stop-gap measures during and following the pandemic.

Already with COVID-19 we are seeing similar disruptions. The pandemic and the response to the pandemic are affecting both the provision and utilisation of reproductive, maternal, newborn, and child health (RMNCH) services.

Amid the pandemic, health workers, equipment, and facilities have been reassigned to address the influx of patients with COVID-19.[@bib12] Restructuring of the health system could result in the closure of peripheral health facilities, as seen in the 2014 Ebola virus outbreak.[@bib13] The health workforce has been further reduced by nosocomial COVID-19 infection and burnout.[@bib14] RMNCH interventions delivered through campaigns (eg, vaccinations, bednets, or vitamin A) are being paused or reduced in scale.[@bib15] COVID-19 has also disrupted the global pharmaceutical and medical supply chain. The low buying power of LMICs and their lack of infrastructure for domestic production are disadvantageous in ensuring a steady supply chain. Global reserves and international procurement mechanisms for essential RMNCH medicines could mitigate shortages;[@bib16] however, interruptions in global transport could affect these channels. In addition, local efforts to contain COVID-19 are likely to negatively impact domestic medical supply chains.

Governments are restricting population movement by closing borders, reducing public transport, halting non-essential activities, and issuing shelter-in-place orders. These restrictions are negatively affecting economies. Lost income, increased prices, and overburdened social safety nets will push vulnerable groups further into poverty and increase financial and other barriers to health-care access. Movement restrictions will reduce physical access, exacerbated by reduced transport availability and the real or perceived threat of prosecution for travelling in public spaces.[@bib17] Demand for RMNCH services might decline as concerns over COVID-19 transmission alter the perceived risk--benefit calculation for individuals deciding to seek care. In many settings, the broader socioeconomic effects of the pandemic will exacerbate food insecurity. Increased poverty, and disrupted food and agriculture systems, will increase reliance on staple foods and restrict access to diverse and nutritious diets.

Given these developments, it seems reasonable to expect disruption to maternal and child health services and increased undernutrition in the coming months. In many LMICs, maternal and child mortality remains high, and hard-won gains could falter without continued attention. Practitioners are already voicing such concerns.[@bib18] WHO released operational guidance for maintaining essential health services and adapting service delivery platforms to avoid interruptions.[@bib3]

Statistical modelling can help to inform policy decisions related to the pandemic. Models have already been used to estimate the direct effects of COVID-19, including on pregnant women and infants.[@bib19] In this study, we add to existing models by estimating the indirect effects of the pandemic on maternal and child mortality in LMICs. While it is still early in the pandemic, a set of realistic, quantifiable estimates will provide a reference point for decision makers currently weighing response strategies.

Methods {#cesec20}
=======

Overview {#cesec30}
--------

We used the Lives Saved Tool (LiST) to estimate additional deaths due to reduced coverage of interventions, and increased prevalence of wasting, under three scenarios and for three time periods. To develop our assumptions, we adopted a simple health systems framework ([figure 1](#fig1){ref-type="fig"}). The framework assumes that four health system components affect coverage of services: availability of health workers, availability of supplies and equipment, demand for services, and access to services. In our analysis, coverage assumes that an intervention is delivered with sufficient quality to achieve its intended health effect.[@bib20] In our framework, availability of health workers and supplies address service readiness; however, other dimensions of service quality are not explicitly captured. Though simplistic, this framework gave us a structure with which to develop scenarios.Figure 1Framework for the effects of health system components on coverage of health services

Scenarios {#cesec40}
---------

We created three scenarios representing different possible futures that might unfold depending on the evolution of the pandemic and the response of governments. We sought to reflect real-world possibilities, based on past epidemics and media reports from the current pandemic. For each scenario, we developed assumptions for the four components in our framework, using the following reduction categories: none (0% reduction), small (5% reduction), moderate (10% reduction), and large (25% reduction). We assumed that provision of health services was a product of workforce and supplies, and that utilisation of health services was a product of demand and access. Coverage was assumed to be a product of provision of health services and utilisation of health services. We used a simple formula to translate component reductions to an overall coverage reduction:

$$\begin{matrix}
{\text{Coverage\ reduction} =} & {1 - (\lbrack 1 - \text{workforce\ reduction}\rbrack)} \\
 & {\times \lbrack 1 - \text{supplies\ reduction}\rbrack} \\
 & {\times \lbrack 1 - \text{demand\ reduction}\rbrack} \\
 & {\times \lbrack 1 - \text{access\ reduction}\rbrack} \\
\end{matrix}$$

The intent of this calculation was to capture the idea that reductions in individual components will combine to produce a greater overall coverage reduction. A more comprehensive analysis would consider the interaction between components.

In addition to coverage reductions, we assumed an increase in the proportion of children who are wasted (low weight for height). Although changes in stunting (low height for age) will only occur and affect mortality in the long term, changes in wasting will affect mortality immediately. For our three scenarios, we assumed 10%, 20%, and 50% relative increases in wasting prevalence, respectively. Given the complex causal pathways for nutrition, these assumptions are necessarily speculative. However, we believe we would miss a large number of potential child deaths if we did not model wasting. The World Food Programme has warned that the number of people facing food crises could double because of the pandemic, so our upper assumption of a 50% relative increase seems within reason.[@bib21]

For scenario 1 ([table 1](#tbl1){ref-type="table"}), we assume small reductions in the availability of health workers and supplies due to the reallocation of resources to the pandemic response. We also assume small reductions in the demand for and access to routine health services, due to movement restrictions, fear of infection, and economic pressure. People become disinclined to seek care for interventions deemed more acceptable to delay or forego, such as antenatal, postnatal, and preventive interventions. Care seekers have difficulty accessing services due to reduced income for out-of-pocket expenses or travel costs.Table 1Component and coverage reductions for three scenarios**Workforce reductionSupplies reductionDemand reductionAccess reductionCoverage reductionScenario 1**[\*](#tbl1fn1){ref-type="table-fn"}Family planningNoneSmallNoneSmall9·8%Antenatal careSmallSmallSmallSmall18·5%Childbirth careSmallSmallNoneSmall14·3%Postnatal careSmallSmallSmallSmall18·5%Early child vaccinationsSmallSmallSmallSmall18·5%Early child preventiveNoneSmallSmallSmall14·3%Early child curativeSmallSmallNoneSmall14·3%**Scenario 2**[\*](#tbl1fn1){ref-type="table-fn"}Family planningSmallModerateNoneSmall18·8%Antenatal careModerateModerateSmallSmall26·9%Childbirth careModerateModerateNoneSmall23·1%Postnatal careModerateModerateSmallSmall26·9%Early child vaccinationsModerateModerateSmallSmall26·9%Early child preventiveSmallModerateSmallSmall22·8%Early child curativeModerateModerateNoneSmall23·1%**Scenario 3**[\*](#tbl1fn1){ref-type="table-fn"}Family planningModerateModerateNoneLarge39·3%Antenatal careLargeModerateSmallLarge51·9%Childbirth careLargeModerateNoneLarge49·4%Postnatal careLargeModerateSmallLarge51·9%Early child vaccinationsLargeModerateSmallLarge51·9%Early child preventiveModerateModerateSmallLarge42·3%Early child curativeLargeModerateNoneLarge49·4%[^1][^2]

In scenario 2 ([table 1](#tbl1){ref-type="table"}), we assume greater disruptions to health systems due to workforce and supply chain issues. Some health workers are diverted to COVID-19 activities, while others become sick or are overwhelmed. Workforce shortages have a greater effect on interventions requiring skilled care (eg, antenatal, childbirth, and curative services); other interventions (eg, contraceptives and preventive services) are less dependent on skilled workers and can more easily be provided by lay health workers. Domestic supply chains are disrupted due to local bottlenecks, resulting in reduced availability of hormonal contraceptives, antenatal supplementation and malaria prevention, commodities for childbirth (eg, uterotonics, corticosteroids, or magnesium sulfate), routine child vaccines, and treatments for common childhood illnesses (eg, antibiotics, antimalarials, or oral rehydration solution).

For scenario 3 ([table 1](#tbl1){ref-type="table"}), in addition to disruptions in the health system, we assume that governments impose strict movement restrictions, forcing families and non-essential workers to stay home. Those with respiratory symptoms or suspected COVID-19 exposure are required to self-isolate. While isolation and shelter-in-place restrictions do not prohibit care seeking, the restrictions reduce access indirectly. Lack of trust in the official health system, and fear of nosocomial infection, prompts some individuals to stop seeking care or to seek care from alternative providers. Stay-at-home orders lead to greater lost income, reduced purchasing power, and inability to pay for services, compounding physical access issues. Travel becomes even more difficult for people who rely on public transport. Access restrictions felt by the broader public also affect health workers, further hampering the health workforce.

Estimating additional deaths {#cesec50}
----------------------------

We used LiST to estimate the additional deaths arising under each scenario. LiST is a causal model that estimates changes in mortality from changes in coverage of interventions.[@bib22] For 17 years, researchers and practitioners have used LiST to estimate the impacts of health programmes.[@bib23] One of LiST\'s strengths is its ability to model the effects of simultaneous changes in 77 interventions along the RMNCH continuum of care, including interventions related to antenatal, childbirth, and postnatal periods, and preventive and curative interventions in early childhood. Through its link to modules on demography and family planning, LiST also estimates the effects of changes in contraceptive prevalence and fertility. More information about LiST and its methodology is provided in the [appendix (p 2)](#sec1){ref-type="sec"}.

We ran our models for 118 of the LMICs tracked by the Countdown to 2030 initiative ([appendix p 5](#sec1){ref-type="sec"}).[@bib24] By our estimates, these countries account for 97·7% of global deaths in children younger than 5 years and 99·6% of global maternal deaths.[@bib25], [@bib26] We modelled each scenario for 1 month, and extrapolated for 3-month, 6-month, and 12-month periods, to aid interpretation. The number of additional deaths in our results represents the increase in deaths compared with a counterfactual of no change in the coverage of interventions or risk factors. We report deaths due to reduced coverage and risk factors only; we do not report deaths arising from an increase in population size from increased fertility driven by reduced contraceptive prevalence, although we do expect these effects in the long term. A link to all our LiST projection files is provided in the [appendix (p 1)](#sec1){ref-type="sec"}.

We included all interventions in LiST for the categories in [table 1](#tbl1){ref-type="table"}. We did not include interventions related to breastfeeding or water and sanitation, as we assumed only a marginal reduction in these activities. As mentioned above, we included wasting, but we did not model stunting, as stunting will not occur in the short term and therefore has no immediate impact on mortality. In LiST, the effect of wasting on mortality is modelled indirectly as a risk factor that increases the likelihood of dying from other infectious causes. We did not include HIV because of the complexity of delivery systems for HIV prevention and treatment, and because HIV accounts for only a small proportion of global child deaths.

Across scenarios, we assumed similar reductions in vaccination coverage as other preventive health services (ie, antenatal and postnatal care). However, we anticipate that herd protection offered by high population vaccination coverage for rotavirus, *Haemophilus influenzae* type b vaccine, and pneumococcal conjugate vaccines will attenuate the effect of temporary reductions. We applied two assumptions in estimating the herd effect of these vaccines. First, 15% of vaccine-preventable child deaths occur in countries that do not have sufficient vaccination coverage for substantial herd protection (eg, Nigeria)[@bib27] and would experience the full immediate effects of decreased vaccination. Second, in countries with higher vaccination coverage, 80% of the unvaccinated cohort would remain protected by the herd effect.[@bib28] Because of the scarcity of evidence on the herd protection offered by meningococcal A vaccine and diphtheria--tetanus--pertussis vaccine, and the high coverage threshold for herd protection for measles vaccine, we did not attenuate the effects of these vaccines; rather, we assumed the full effect of the coverage reduction on mortality.

Role of the funding source {#cesec60}
--------------------------

The funders of the study had no role in study design, data analysis, data interpretation, or writing of the report. All authors had access to all the data in the study and had final responsibility for the decision to submit for publication.

Results {#cesec70}
=======

[Table 2](#tbl2){ref-type="table"} shows the estimated additional maternal and child deaths for each scenario among all 118 countries. These numbers represent the deaths due specifically to the reductions in coverage and increase in wasting---ie, deaths that would not occur if coverage and wasting instead stayed constant. We report child deaths excluding and including the effects of increased wasting. The estimates are reported for a 1-month period (per month) and extrapolated for 3-month, 6-month, and 12-month periods. The estimates do not reflect deaths during transition periods in which coverage is decreasing or returning to baseline. The number of additional deaths increases with the severity of the coverage reductions and wasting increases, with scenario 1 (smallest reductions) resulting in an additional 2030 maternal deaths and 42 240 child deaths per month, and scenario 3 (greatest reductions) resulting in an additional 9450 maternal deaths and 192 830 child deaths per month. Country-specific numbers are provided in the [appendix (p 443)](#sec1){ref-type="sec"}.Table 2Additional deaths for each scenario among all modelled countries (n=118)**Per monthAdditional deaths, n**Baseline deaths, nAdditional deaths, nRelative increase3 months6 months12 months**Maternal deaths**Scenario 124 50020308·3%610012 20024 400Scenario 224 500360014·7%10 80021 60043 100Scenario 324 500945038·6%28 30056 700113 400**Child deaths, excluding the effect of increased wasting**Scenario 1431 69034 7508·0%104 300208 500417 000Scenario 2431 69058 91013·6%176 700353 500706 900Scenario 3431 690148 87034·5%446 600893 2001 786 400**Child deaths, including the effect of increased wasting**Scenario 1431 69042 2409·8%126 700253 500506 900Scenario 2431 69074 53017·3%223 600447 200894 400Scenario 3431 690192 83044·7%578 5001 157 0002 313 900

[Table 2](#tbl2){ref-type="table"} and [figure 2](#fig2){ref-type="fig"} show additional deaths compared with baseline deaths in a no-change scenario. Currently, there are approximately 24 500 maternal deaths and 431 690 child deaths per month in the 118 countries.[@bib25], [@bib26] The additional maternal deaths would represent relative increases of 8·3% (scenario 1), 14·7% (scenario 2), and 38·6% (scenario 3) in maternal deaths per month. The additional child deaths would represent relative increases of 9·8% (scenario 1), 17·3% (scenario 2), and 44·7% (scenario 3) in child deaths per month.Figure 2Baseline and additional maternal and child deaths per month by scenarioSee [table 2](#tbl2){ref-type="table"} for values.

[Table 3](#tbl3){ref-type="table"}, [Table 4](#tbl4){ref-type="table"} show the contributions of individual interventions to total additional maternal and child deaths. This ranking is driven by the country-specific baseline coverage of each intervention, by the assumed coverage reductions for each intervention in our scenarios, and by the strength of each intervention on averting mortality (based on intervention efficacy and underlying country-specific causes of mortality). The reduced coverage of four childbirth interventions (namely, parenteral administration of uterotonics, antibiotics, and anticonvulsants, and clean birth environments, which reduce mortality due to post-partum haemorrhage, maternal sepsis, and eclampsia) would account for approximately 60% of additional maternal deaths ([table 3](#tbl3){ref-type="table"}). In children, an increase in wasting prevalence would account for 18--23% of additional deaths, depending on the scenario, while reduced coverage of antibiotics for pneumonia and neonatal sepsis and of oral rehydration solution for diarrhoea would together account for around 41% of additional child deaths ([table 4](#tbl4){ref-type="table"}).Table 3Additional maternal deaths per month by intervention among all modelled countries (n=118)**CategoryAdditional maternal deaths**Scenario 1Scenario 2Scenario 3Total additional deaths..203036009450Parenteral administration of uterotonicsChildbirth557 (28%)1008 (28%)2775 (29%)Parenteral administration of antibioticsChildbirth236 (12%)433 (12%)1245 (13%)Parenteral administration of anticonvulsantsChildbirth194 (10%)351 (10%)968 (10%)Clean birth environmentChildbirth180 (9%)328 (9%)931 (10%)Contraceptive useFamily planning130 (6%)247 (7%)514 (5%)Magnesium sulfate management of pre-eclampsiaAntenatal135 (7%)212 (6%)483 (5%)Micronutrient supplementation (iron and multiple micronutrients)Antenatal101 (5%)159 (4%)361 (4%)Antibiotics for preterm or prolonged premature rupture of membranesChildbirth78 (4%)143 (4%)411 (4%)Manual removal of placentaChildbirth50 (3%)90 (3%)245 (3%)Removal of retained products of conceptionChildbirth46 (2%)82 (2%)223 (2%)Hypertensive disorder case managementAntenatal51 (3%)80 (2%)182 (2%)Blood transfusionChildbirth41 (2%)73 (2%)198 (2%)Households protected from malaria (insecticide-treated nets or indoor residual spraying)Antenatal39 (2%)70 (2%)152 (2%)Safe abortion servicesFamily planning29 (1%)67 (2%)193 (2%)Tetanus toxoid vaccinationAntenatal37 (2%)59 (2%)135 (1%)Malaria case managementAntenatal30 (2%)48 (1%)111 (1%)Intermittent preventive treatment of malaria in pregnancyAntenatal28 (1%)43 (1%)102 (1%)Assisted vaginal deliveryChildbirth22 (1%)39 (1%)99 (1%)Caesarean deliveryChildbirth17 (1%)31 (1%)82 (1%)[^3]Table 4Additional child deaths per month by intervention among all modelled countries (n=118)**CategoryAdditional child deaths**Scenario 1Scenario 2Scenario 3Total additional deaths..42 24074 530192 830Increase in wasting prevalenceWasting7430 (18%)15 550 (21%)43 810 (23%)Case management of neonatal sepsis or pneumoniaCurative7770 (18%)12 920 (17%)34 390 (18%)Oral antibiotics for pneumoniaCurative6920 (16%)11 760 (16%)28 710 (15%)Oral rehydration solutionCurative3380 (8%)5840 (8%)14 800 (8%)Thermal protectionChildbirth2030 (5%)3670 (5%)9960 (5%)Clean cord careChildbirth1760 (5%)3280 (4%)9730 (3%)Tetanus toxoid vaccinationAntenatal1910 (4%)2970 (4%)6610 (5%)Neonatal resuscitationChildbirth1280 (3%)2280 (3%)6000 (3%)Immediate drying and additional stimulationChildbirth1170 (3%)2080 (3%)5430 (3%)Clean birth environmentChildbirth890 (2%)1630 (2%)4600 (2%)Measles vaccineVaccines1030 (2%)1540 (2%)3160 (1%)Vitamin A for treatment of measlesCurative850 (2%)1520 (2%)4230 (2%)Diphtheria--tetanus--pertussis vaccineVaccines950 (2%)1410 (2%)2890 (2%)Vitamin A supplementationPreventive830 (2%)1350 (2%)2550 (1%)Assisted vaginal deliveryChildbirth520 (1%)920 (1%)2400 (1%)*Haemophilus influenzae* type b vaccineVaccines560 (1%)830 (1%)1720 (1%)Antibiotics for preterm or prolonged premature rupture of membranesChildbirth420 (1%)750 (1%)1960 (1%)Parenteral administration of antibioticsChildbirth420 (1%)750 (1%)1960 (1%)Pneumococcal conjugate vaccineVaccines460 (1%)690 (1%)1410 (1%)Artemisinin-based combination therapies for treatment of malariaCurative330 (1%)530 (1%)1170 (1%)Zinc for treatment of diarrhoeaCurative260 (1%)450 (1%)1140 (1%)Antibiotics for treatment of dysenteryCurative200 (\<1%)350 (\<1%)860 (\<1%)Caesarean deliveryChildbirth180 (\<1%)320 (\<1%)840 (\<1%)Households protected from malaria (insecticide-treated nets or indoor residual spraying)Preventive130 (\<1%)230 (\<1%)520 (\<1%)Meningococcal A vaccineVaccines130 (\<1%)190 (\<1%)380 (\<1%)Complementary feedingPreventive110 (\<1%)190 (\<1%)360 (\<1%)Maternal age and birth orderFamily planning70 (\<1%)160 (\<1%)410 (\<1%)Intermittent preventive treatment of malaria in pregnancyAntenatal90 (\<1%)140 (\<1%)330 (\<1%)Rotavirus vaccineVaccines60 (\<1%)90 (\<1%)190 (\<1%)Syphilis detection and treatmentAntenatal40 (\<1%)70 (\<1%)160 (\<1%)[^4]

Discussion {#cesec80}
==========

Our analysis shows that if the COVID-19 pandemic results in widespread disruption to health systems and reduced access to food, LMICs can expect to see large increases in maternal and child deaths. Under our first scenario (coverage reductions of 9·8--18·5% and wasting increase of 10%), over 6 months there would be 253 500 additional child deaths and 12 200 additional maternal deaths. Under our third scenario (coverage reductions of 39·3--51·9% and wasting increase of 50%), over 6 months there would be 1 157 000 additional child deaths and 56 700 additional maternal deaths. These deaths would represent a 9·8--44·7% increase in under-5 child deaths per month, and an 8·3--38·6% increase in maternal deaths per month, across the 118 countries.

We do not intend our estimates as a prediction. Instead, we aim to show what could happen under scenarios of differing severity and duration. If countries are successful in minimising disruptions to their health systems and maintaining utilisation of RMNCH services, the number of additional deaths will be at the smaller end of our estimates. Although this might seem obvious, we see three important messages that come from this exercise.

First, the choices that governments make in responding to the pandemic will have consequences for maternal and child health. There has been debate around the trade-off between establishing movement restrictions and minimising disruptions to business and economies. Our results show that the indirect effects of the pandemic are not merely economic. If the delivery of health care is disrupted, many women and children will die. Thus, while public health experts are advocating for social distancing, there is also a public health case for ensuring access to routine care. Our estimates quantify the potential effect on RMNCH and provide a reference point for policy makers.

Second, not all health interventions are similarly susceptible to disruption or have the same effect. As policy makers consider plans to reallocate staff and resources, they might need to prioritise interventions. In our scenarios, maintaining coverage of four childbirth interventions (parenteral administration of uterotonics, antibiotics, and anticonvulsants, and clean birth environments) would save 60% of additional maternal deaths. Maintaining coverage of antibiotics for neonatal sepsis and pneumonia and oral rehydration solution for diarrhoea would save 41% of additional child deaths. Disruption of these interventions---childbirth and child curative services---cannot be mitigated through post-outbreak activities or easily averted through vertical health programmes outside of the public health system. The vulnerability of these interventions to disruption, and their substantial consequences for mortality, highlight the need to ensure provision of these services throughout the pandemic and support citizens in using these services as safely as possible.

In our scenarios, increases in childhood wasting accounted for 18--23% of additional child deaths. Although our assumptions for this were speculative, we are confident that, if wasting does increase, it will contribute greatly to child mortality. The drivers of wasting might lie outside of the health system, but there are interventions that health policy makers could consider (eg, ready-to-use therapeutic foods). More importantly, multisectoral action should be taken to mitigate increases in wasting by strengthening and expanding social safety nets and by supporting local food and agricultural systems.

Thanks to country prioritisation and the efforts of initiatives such as Gavi, the Vaccine Alliance, coverage of essential child immunisations is high in most LMICs. This high coverage grants herd protection for some vaccine-preventable diseases, attenuating the immediate effects of coverage declines on mortality. However, even short gaps in vaccination coverage can result in overall declines in population coverage, and catch-up campaigns should be prioritised in the aftermath of the pandemic.[@bib15]

Third, once the pandemic is over, health systems must recover quickly. As life returns to normal, countries should advance resilient health systems and reinvigorate demand for routine care. The longer that coverage reductions continue, the more lives will be lost. Once care-seeking patterns are broken, they might be hard to reinstate. We should not delay in restoring health services as soon as possible if we are to minimise the lasting impact of otherwise temporary disruptions.

We stress that our scenarios are meant as hypothetical futures, to show the potential effects on maternal and child mortality if they were to occur. We are still early in the pandemic, and our assumptions could prove to be too severe or too conservative. There is not yet reliable empirical data for the effect of the pandemic on health service provision or utilisation. Moreover, our understanding of what might be possible is based largely on experiences in high-income countries; the effects of the pandemic in LMICs, and the response to it, will probably be different.[@bib29] For all these reasons, our results are intended to help understand the potential magnitude of the effect, not to offer exact or even approximate numbers.

We applied the same assumptions to 118 countries, and in our above results we only report aggregate numbers. Country-specific estimates can be found in the [appendix (p 443)](#sec1){ref-type="sec"}. We hesitate to showcase our estimates by country because we did not incorporate information on country-specific response strategies and, without this, deeper comparisons by country are limited. However, we recognise that the principal actors who need our estimates are national decision makers. We encourage those considering country-specific scenarios to use LiST, and the projection files provided in the [appendix](#sec1){ref-type="sec"}, to investigate the indirect effects of the pandemic using assumptions tailored to their context.

LiST is constrained to a defined set of health-sector interventions, and does not estimate the effects of income, agriculture, or food markets on stunting and wasting (although changes to stunting and wasting can be entered directly). A more complex analysis might attempt to model these upstream factors. Similarly, a comprehensive analysis would consider in more detail the long-term effect of temporary reductions in vaccine coverage (assuming no catch-up campaigns), the long-term effect of fertility increases due to temporary reductions in contraceptive prevalence, and the additional deaths during a post-pandemic period in which coverage is returning to baseline. LiST does not capture individual infectious disease dynamics and therefore does not reflect the potential effects of secondary outbreaks in the absence of preventive interventions (eg, localised measles outbreaks due to a gap in measles vaccination), as modelled in other analyses.[@bib30] In general, we expect the pandemic to affect the health of women and children in more ways than we have captured, not fewer, including through causal pathways unknown to us now. If our estimates are overly conservative, they still highlight the need to consider maternal and child health amid the pandemic and the consequences at stake.

Supplementary Material {#sec1}
======================
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[^1]: Small=5% reduction. Moderate=10% reduction. Large=25% reduction.

[^2]: In addition to coverage reductions, we assumed that the proportions of children with wasting would be increased by 10% in scenario 1, 20% in scenario 2, and 50% in scenario 3.

[^3]: Data are n (% of total deaths).

[^4]: Data are n (% of total deaths).
